


| Key | % Net Assets |
|---|---|
| 5.3% | |
| 4.6% | |
| 4.5% | |
| 4.2% | |
| 81.4% |
| Name | % Net Assets |
|---|---|
| AstraZeneca | 5.3% |
| GlaxoSmithKline | 4.6% |
| Vodafone Group | 4.5% |
| Legal & General Group | 4.2% |
| Logica | 4.2% |
| Resolution | 3.0% |
| Royal Bank of Scotland | 2.9% |
| Old Mutual | 2.8% |
| Henry Boot | 2.8% |
| Taylor Wimpey | 2.7% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| NAV | 16,630.00p |
| Currency | GBP |
| Change | -60.00p |
| % | -0.36% |
| YTD change | 2,010.00p |
| YTD % | 13.75% |
| Fund Inception | 05/05/1970 |
|---|---|
| Fund Manager | Kevin Murphy / Nick Kirrage |
| TER | 1.52 (15-Jul-2012) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | n/a |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.19 |
You are here: research